Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Epidemiology of invasive and non-invasive pneumococcal infections in hospitalised adult patients in a Lebanese medical centre, 2006-2015.

Moghnieh R, Tamim H, Awad L, Abdallah D, Sleiman R, Jisr T, Al-Helou M, Ibrahim A, Mugharbil A, Droubi N, Reslan L, Matar GM, Dbaibo G.

J Infect Public Health. 2019 Apr 1. pii: S1876-0341(19)30112-1. doi: 10.1016/j.jiph.2019.03.003. [Epub ahead of print]

2.

Characterization of astrovirus-associated gastroenteritis in hospitalized children under five years of age.

Zaraket H, Abou-El-Hassan H, Kreidieh K, Soudani N, Ali Z, Hammadi M, Reslan L, Ghanem S, Hajar F, Inati A, Rajab M, Fakhouri H, Ghanem B, Baasiri G, Melhem NM, Dbaibo G.

Infect Genet Evol. 2017 Sep;53:94-99. doi: 10.1016/j.meegid.2017.05.016. Epub 2017 May 20.

PMID:
28536072
3.

Rotavirus Genotypes and Vaccine Effectiveness from a Sentinel, Hospital-Based, Surveillance Study for Three Consecutive Rotavirus Seasons in Lebanon.

Ali Z, Harastani H, Hammadi M, Reslan L, Ghanem S, Hajar F, Sabra A, Haidar A, Inati A, Rajab M, Fakhouri H, Ghanem B, Baasiri G, Gerbaka B, Zaraket H, Matar GM, Dbaibo G.

PLoS One. 2016 Aug 29;11(8):e0161345. doi: 10.1371/journal.pone.0161345. eCollection 2016.

4.

The Novel PKCθ from Benchtop to Clinic.

Hage-Sleiman R, Hamze AB, Reslan L, Kobeissy H, Dbaibo G.

J Immunol Res. 2015;2015:348798. doi: 10.1155/2015/348798. Epub 2015 May 19. Review.

5.

Preclinical activity of the type II CD20 antibody GA101 (obinutuzumab) compared with rituximab and ofatumumab in vitro and in xenograft models.

Herter S, Herting F, Mundigl O, Waldhauer I, Weinzierl T, Fauti T, Muth G, Ziegler-Landesberger D, Van Puijenbroek E, Lang S, Duong MN, Reslan L, Gerdes CA, Friess T, Baer U, Burtscher H, Weidner M, Dumontet C, Umana P, Niederfellner G, Bacac M, Klein C.

Mol Cancer Ther. 2013 Oct;12(10):2031-42. doi: 10.1158/1535-7163.MCT-12-1182. Epub 2013 Jul 19.

6.

Apoptotic induction by anti-CD20 antibodies in chronic lymphocytic leukemia: comparison of rituximab and obinutuzumab.

Reslan L, Dalle S, Herveau S, Perrial E, Dumontet C.

Leuk Lymphoma. 2014 Jan;55(1):188-90. doi: 10.3109/10428194.2013.788175. Epub 2013 May 7. No abstract available.

PMID:
23537278
7.

Preclinical studies on the mechanism of action and the anti-lymphoma activity of the novel anti-CD20 antibody GA101.

Dalle S, Reslan L, Besseyre de Horts T, Herveau S, Herting F, Plesa A, Friess T, Umana P, Klein C, Dumontet C.

Mol Cancer Ther. 2011 Jan;10(1):178-85. doi: 10.1158/1535-7163.MCT-10-0385.

8.

Identification of Mycoplasma mycoides subsp. mycoides small colony genes coding for T-cell antigens.

Totté P, Mather A, Reslan L, Boublik Y, Niang M, Du Plessis D, Dedieu L.

Clin Vaccine Immunol. 2010 Aug;17(8):1211-6. doi: 10.1128/CVI.00132-10. Epub 2010 Jun 9.

9.

Understanding and circumventing resistance to anticancer monoclonal antibodies.

Reslan L, Dalle S, Dumontet C.

MAbs. 2009 May-Jun;1(3):222-9. Epub 2009 May 24. Review.

10.

Transfection of cells in suspension by ultrasound cavitation.

Reslan L, Mestas JL, Herveau S, Béra JC, Dumontet C.

J Control Release. 2010 Mar 3;142(2):251-8. doi: 10.1016/j.jconrel.2009.10.029. Epub 2009 Nov 6.

PMID:
19896995
11.

In vivo model of follicular lymphoma resistant to rituximab.

Dalle S, Dupire S, Brunet-Manquat S, Reslan L, Plesa A, Dumontet C.

Clin Cancer Res. 2009 Feb 1;15(3):851-7. doi: 10.1158/1078-0432.CCR-08-1685.

Supplemental Content

Loading ...
Support Center